Internal Server Error

Cofactor Genomics - About the company

Cofactor Genomics is a series A company based in San Francisco (United States), founded in 2009 by Dave Messina. It operates as a Developer of diagnostic assays using RNA sequencing. Cofactor Genomics has raised $26.2M in funding from investors like Y Combinator, Menlo Ventures and 7percent Ventures, with a current valuation of $*****. The company has 16 active competitors, including 6 funded and 1 that has exited. Its top competitors include companies like Veracyte, HAYA Therapeutics and Alida Biosciences.

Company Details

Developer of diagnostic assays using RNA sequencing. The company's product includes ImmunoPrism is an RNA sequencing-based assay that uses predictive immune modeling to generate multidimensional biomarkers. It combines machine learning and RNA-sequencing to build gene expression models for immune cells. The company's models for key immune cells include Immune Health Expression Models, Immune Escape Genes, and Co-inhibitory molecules. The company's sequencing products include mRNAble, Total RNAble, picoRNA, FFPExact, miRNAble, RNAccess, RNAmplify, and RNAdvantage.
Social
XFacebook
Email ID
*****@cofactorgenomics.com
Phone Number
+1 **********
Registered Address
St. Louis, Missouri
Key Metrics
Founded Year
2009
Location
San Francisco, United States
Stage
Series A
Total Funding
$26.2M in 7 rounds
Latest Funding Round
Post Money Valuation
$***** as on Jan 01, 2015
Ranked
Employee Count
13 as on Sep 30, 2026
Investment & Acquisitions
Similar Companies
Sign up to download Cofactor Genomics' company profile

Cofactor Genomics's funding and investors

Cofactor Genomics has raised a total funding of $26.2M over 7 rounds. Its first funding round was on Sep 01, 2014. Its latest funding round was a Series A round on Dec 15, 2025 for $*****. 2 investors participated in its latest round. Cofactor Genomics has 20 institutional investors.

Here is the list of recent funding rounds of Cofactor Genomics:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Dec 15, 2025
4122772
Series A
7731542
2020920
1180800
5223366
Aug 02, 2023
1392109
Series A
8836518
4288070
6979872
4913155
Dec 16, 2021
9718635
Series A
9243937
2683224
3926014
2220992
lockAccess funding benchmarks and valuations. Sign up today!

Cofactor Genomics' founders and board of directors

Founder? Claim Profile
The founders of Cofactor Genomics is Dave Messina.
Here are the details of Cofactor Genomics' key team members:

Cofactor Genomics' Board of Directors

Cofactor Genomics's board has 8 active members. William Hagstrom, Armen A Vidian, Mark Siegel, John Kuelper, Jarret Glasscock, Matthew A. Ocko, Jarret Glassock and David Messina are independent board members.
Here is the list of Cofactor Genomics' board of directors:
Name
Type
Representing
Status
Duration
Independent board member
-
Current
4y 10m
kbipsvk
Independent board member
-
Current
3y 2m
lfa{{lv
Independent board member
-
Current
9y 1m
lhcuxrt
Independent board member
-
Current
4y 9m
ogsdxzc
Independent board member
-
Current
1y 2m
jbaxxhi
Independent board member
-
Current
3y 1m
uqcacfo
Independent board member
-
Current
4y 1m
o{jdwdy
Independent board member
-
Current
1y 8m

Cofactor Genomics' employee count trend

Cofactor Genomics has 13 employees as of Sep 26. Here is Cofactor Genomics's employee count trend over the years:
Employee count trend for Cofactor Genomics
lockUncover Cofactor Genomics' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Cofactor Genomics's Competitors and alternates

Top competitors of Cofactor Genomics include Veracyte, HAYA Therapeutics and Alida Biosciences. Here is the list of Top 10 competitors of Cofactor Genomics, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Veracyte
Veracyte
2008, San Francisco (United States), Public
Developer of genomics-based diagnostics for cancer
$67.9M
63/100
2nd
Logo for HAYA Therapeutics
HAYA Therapeutics
2017, Lausanne (Switzerland), Series A
Developer of RNA-based therapies for treating heart diseases
$90M
60/100
3rd
Logo for Cofactor Genomics
Cofactor Genomics
2009, San Francisco (United States), Series A
Developer of diagnostic assays using RNA sequencing
$26.2M
55/100
4th
Logo for Alida Biosciences
Alida Biosciences
2020, San Diego (United States), Series A
Provider of technology for RNA analysis to improve human health
$11.5M
55/100
5th
Logo for Novigenix
Novigenix
2014, Epalinges (Switzerland), Series B
Developer of technology for cancer precision medicine
$20M
49/100
6th
Logo for Cajal Neuroscience
Cajal Neuroscience
2020, Seattle (United States), Series A
Developer of drugs for neurodegenerative disease based on genetic screening, and multi-omics approach
$96M
43/100
7th
Logo for Isoma Diagnostics
Isoma Diagnostics
2017, Philadelphia (United States), Funding Raised
Molecular diagnostic tests for stratification of Glioblastoma
-
29/100
8th
Logo for Biomedica Immunoassays
Biomedica Immunoassays
1992, Vienna (Austria), Unfunded
Developer of ELISAs kits for detecting circulating microRNAs
-
-
28/100
9th
Logo for PeriRx
PeriRx
2008, Broomall (United States), Funding Raised
Developer of saliva-based risk stratification test for oral cancer
-
27/100
10th
Logo for Nova Satra
Nova Satra
2014, Singapore (Singapore), Seed
Provider of non-invasive diagnostic tests for cancer
$2M
25/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Cofactor Genomics's competitors? Click here to see the top ones

Cofactor Genomics's Investments and acquisitions

Cofactor Genomics has acquired Narus Biotechnologies. Cofactor Genomics has not made any investments as of now.

Reports related to Cofactor Genomics

Here is the latest report on Cofactor Genomics's geography:

News related to Cofactor Genomics

lockFilter this list
Media has covered Cofactor Genomics for 1 event in last 1 year.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Cofactor Genomics

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford